A new point-of-care diagnostic solution aims to make effective care more accessible for millions of HIV patients, consistent with UNAIDS' 90-90-90 goals.
Editor's Note: This article originally appeared on Abbott's website.
Amsterdam, July 24, 2018 – Today, Abbott is proud to introduce the m-PIMA HIV-1/2 VL, the first viral load point-of-care test designed to provide healthcare professionals, especially in remote and underserved communities, with a fast, accurate and easy-to-use test to manage HIV.
By providing viral load test results in less than 70 minutes, this life-changing technology allows patients to get tested and treated in the same visit and then get back to leading their best life. Click here continue >>
News from our partners